Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Feb;37(2):376-9.
doi: 10.1128/JCM.37.2.376-379.1999.

Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2

D S Schmid  1 , D R Brown, R Nisenbaum, R L Burke, D Alexander, R Ashley, P E Pellett, W C Reeves
Affiliations

Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2

D S Schmid et al. J Clin Microbiol. 1999 Feb.

Abstract

Type-specific serologic assays for herpes simplex virus (HSV) types 1 and 2 based on glycoprotein G-1 (gG-1) (HSV-1) and gG-2 (HSV-2) discriminate between antibodies against HSV-1 and HSV-2. We previously developed a Western blot assay using gG-1 and gG-2 expressed in baculovirus, performed extensive validation studies, and determined that it was both sensitive and specific for type-specific detection of HSV antibody. Here we report that, among a cohort of Thai military recruits, the serostatus of some individuals changed from positive to negative over time (6.6% among those ever positive for HSV-1, and 14.9% among those ever positive for HSV-2). We tested a subset of these specimens in three other gG-based assays: an enzyme-linked immunosorbent assay, an immunoblot strip assay, and a Western blot assay. Positive-to-negative shifts occurred in every assay; the frequency of the shifts ranged from 6. 1% to 21.2% of the specimen sets tested. There was only limited agreement among the assays concerning which individuals lost reactivity. This inaccuracy, exhibited by all of the assay protocols, was not predicted by validation studies employing specimens from cross-sectional studies and was most pronounced in HSV-2 testing. This argues for the inclusion of serial blood specimens in serologic assay validation procedures.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Comparison of HSV-2 results from selected sequential serum sets among four gG-based serologic methods. Note that the sets were not consistent in all four assay methods.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alexander D, Kilpatrick J, Ashley R, Corey L, Dinello R, Polito A, Burke R L. Recombinant-truncated gG1 and gG2 as antigens for a type-specific serological assay to diagnose prior infection with HSV-1 or HSV-2, abstr. 283. Vancouver, Canada: International Herpesvirus Workshop; 1994.
    1. Ashley R. Herpes simplex virus. In: Lennette E, editor. Diagnostic procedures for viral, rickettsial and chlamydial infections. 7th ed. Washington, D.C: American Public Health Association; 1995. pp. 375–395.
    1. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med. 1994;121:847–854. - PubMed
    1. Bernstein D I, Lovett M A, Bryson Y J. Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Am J Med. 1984;77:1055–1060. - PubMed
    1. Brown Z A, Benedetti J K, Watts D H, Selke S, Berry S, Ashley R L, Corey L. A comparison between detailed and simple histories in the diagnosis of genital herpes complicating pregnancy. Am J Obstet Gynecol. 1995;172:1299–1303. - PubMed

MeSH terms

Substances